Jane Swift
Known title: DirectorCIK: 0001307744
Associated companies
Transaction History
| SPH | ▼ Sell | Open Market | 148 | $2K | 9/29/2026 | View on chart |
| SPH | ▼ Sell | Open Market | 364 | $6K | 9/28/2026 | View on chart |
| SPH | ▲ Buy | Option Exercise | 2,354 | $44K | 11/14/2025 | View on chart |
| SPH | ▼ Sell | Other | 2,354 | $44K | 11/14/2025 | View on chart |
| SPH | ▼ Sell | Open Market | 7,438 | $139K | 11/26/2024 | View on chart |
| SPH | ▲ Buy | Grant | 13,112 | $0 | 11/15/2024 | View on chart |
| SPH | ▼ Sell | Open Market | 16,261 | $248K | 11/16/2021 | View on chart |
| SPH | ▲ Buy | Grant | 22,316 | $0 | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SeekingAlpha Highlights SPH as Safer High‑Dividend Small‑Cap
SeekingAlpha's recent piece labels SPH as a high‑dividend small‑cap, noting its 7.56% yield and P/E of 8.5. The author calls it a safer option among "toy dogs" for October. This highlights SPH’s appeal to income‑focused investors and its position within a narrow 52‑week range.
SeekingAlpha Highlights SPH as Safer High‑Dividend Small‑Cap. SeekingAlpha's recent piece labels SPH as a high‑dividend small‑cap, noting its 7.56% yield and P/E of 8.5. The author calls it a safer option among "toy dogs" for October. This highlights SPH’s appeal to income‑focused investors and its position within a narrow 52‑week range.